176 related articles for article (PubMed ID: 14531784)
1. New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.
Goodman WG
Kidney Int Suppl; 2003 Nov; (87):S120-4. PubMed ID: 14531784
[TBL] [Abstract][Full Text] [Related]
2. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
Salusky IB; Goodman WG; Kuizon BD; Lavigne JR; Zahranik RJ; Gales B; Wang HJ; Elashoff RM; Jüppner H
Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy.
Goodman WG; Jüppner H; Salusky IB; Sherrard DJ
Kidney Int; 2003 Jan; 63(1):1-11. PubMed ID: 12472763
[TBL] [Abstract][Full Text] [Related]
4. Assays for parathyroid hormone and their use in patients with end-stage renal disease.
Goodman WG
Blood Purif; 2003; 21(1):118-23. PubMed ID: 12596757
[TBL] [Abstract][Full Text] [Related]
5. Immunoassays for the detection of parathyroid hormone.
Jüppner H; Potts JT
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
[TBL] [Abstract][Full Text] [Related]
6. New PTH assays and renal osteodystrophy.
Salusky IB; Jüppner H
Pediatr Nephrol; 2004 Jul; 19(7):709-13. PubMed ID: 15173936
[TBL] [Abstract][Full Text] [Related]
7. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
Lehmann G; Stein G; Hüller M; Schemer R; Ramakrishnan K; Goodman WG
Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
[TBL] [Abstract][Full Text] [Related]
8. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
Gao P; D'Amour P
Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone: new assays, new receptors.
Martin KJ; Akhtar I; González EA
Semin Nephrol; 2004 Jan; 24(1):3-9. PubMed ID: 14730504
[TBL] [Abstract][Full Text] [Related]
10. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
Reichel H; Esser A; Roth HJ; Schmidt-Gayk H
Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
[TBL] [Abstract][Full Text] [Related]
11. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
Cantor T; Sci B
Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
[TBL] [Abstract][Full Text] [Related]
12. Practical considerations in PTH testing.
Souberbielle JC; Friedlander G; Cormier C
Clin Chim Acta; 2006 Apr; 366(1-2):81-9. PubMed ID: 16310759
[TBL] [Abstract][Full Text] [Related]
13. PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease.
Coen G; Bonucci E; Ballanti P; Balducci A; Calabria S; Nicolai GA; Fischer MS; Lifrieri F; Manni M; Morosetti M; Moscaritolo E; Sardella D
Am J Kidney Dis; 2002 Aug; 40(2):348-54. PubMed ID: 12148108
[TBL] [Abstract][Full Text] [Related]
14. Variable parathyroid hormone(1-84)/carboxylterminal PTH ratios detected by 4 novel parathyroid hormone assays.
Koller H; Zitt E; Staudacher G; Neyer U; Mayer G; Rosenkranz AR
Clin Nephrol; 2004 May; 61(5):337-43. PubMed ID: 15182128
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone assays--evolution and revolutions in the care of dialysis patients.
Malluche HH; Mawad H; Trueba D; Monier-Faugere MC
Clin Nephrol; 2003 May; 59(5):313-8. PubMed ID: 12779091
[TBL] [Abstract][Full Text] [Related]
16. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
[TBL] [Abstract][Full Text] [Related]
17. Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy.
Andress DL; Endres DB; Maloney NA; Kopp JB; Coburn JW; Sherrard DJ
J Clin Endocrinol Metab; 1986 Nov; 63(5):1163-9. PubMed ID: 3760116
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intact and 'whole molecule' parathyroid hormone assays in patients with histologically confirmed post-renal transplant osteodystrophy.
Godber IM; Parker CR; Lawson N; Hitch T; Porter CJ; Roe SD; Cassidy MJ; Hosking DJ
Ann Clin Biochem; 2002 May; 39(Pt 3):314-7. PubMed ID: 12038608
[TBL] [Abstract][Full Text] [Related]
19. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.
Coen G; Ballanti P; Bonucci E; Calabria S; Costantini S; Ferrannini M; Giustini M; Giordano R; Nicolai G; Manni M; Sardella D; Taggi F
Nephron; 2002 May; 91(1):103-11. PubMed ID: 12021526
[TBL] [Abstract][Full Text] [Related]
20. Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio.
Fehmi H; Osman Y; Bhat S; Nguyen K; Daramola O; Cantor T; Monier-Faugere MC; Yee J; Malluche HH
Clin Nephrol; 2009 Mar; 71(3):267-75. PubMed ID: 19281737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
